Table 1 The Clinical Characteristics of the 75 patients
Parameter | Â | Value |
|---|---|---|
Gender-no.(%) | No. of Male(%) | 48 (64.0%) |
No.of Female(%) | 27 (36.0%) | |
Mean age-mean ± SD (yr) | All subjects | 48.8 ± 14.1 |
Male | 49.0 ± 13.5 | |
Female | 48.4 ± 15.4 | |
Body mass index-mean ± SD (kg/m2) | 27.5 ± 11.2 | |
ECOG performance status-no.(%) | 0 | 18 (24.0%) |
1 | 57 (76.0%) | |
CEA Level-mean ± SD (ng/ml) | Pre-Immunotherapy | 160.2 ± 411.3 |
Post-Immunotherapy | 284.4 ± 890.5 | |
CA199 Level-mean ± SD (ng/ml) | Pre-Immunotherapy | 387.3 ± 1271.7 |
Post-Immunotherapy | 512.8 ± 2037.1 | |
Previous therapies-no.(%) | Surgery | 53 (70.7%) |
Chemotherapy | 73 (97.3%) | |
Radiotherapy | 13 (17.3%) | |
Target cancer therapy | 49 (65.3%) | |